the cost of bipolar disorder

Bipolar disorder imposes a significant economic burden worldwide, encompassing both direct healthcare expenses and indirect costs such as lost productivity and caregiver support. While comprehensive global data are limited, studies from specific countries provide insight into the financial impact of this condition.

United States:

• Total Economic Burden: The annual economic burden of bipolar disorder in the U.S. is estimated to be approximately $202 billion.

• Cost Distribution: Indirect costs, including unemployment, productivity loss, and caregiver burden, constitute about 72% of the total costs. Direct healthcare costs, such as hospitalizations and outpatient visits, account for approximately 25%, or $46 billion annually.

United Kingdom:

• Per Patient Costs: The average annual cost per patient with bipolar disorder is around £14,938, with 68% attributed to lost productivity and informal care, and 31% to healthcare costs.

• National Economic Burden: The total annual economic burden of bipolar disorder in the UK is estimated at £6.43 billion.

These figures underscore the substantial economic impact of bipolar disorder, highlighting the importance of effective management strategies to mitigate both direct and indirect costs.